
Abbott Laboratories
Healthcare · USD
Price
$102.3
Cap
$178.4B
Earnings
2/4 beat
30d Trend
-1%
Near 52-week lows — potential value or falling knife
Target range: $122 – $158 (consensus: $135.46)
Consensus: Buy
Earnings history
Q4 2025
MET
1.5 vs 1.5
Q3 2025
MET
1.3 vs 1.3
Q2 2025
BEAT
1.26 vs 1.25
Q1 2025
BEAT
1.09 vs 1.07
Key macro factors
Global macroeconomic conditions, including inflation, labor shortages, and geopolitical risks, which can impact Abbott's extensive international operations and supply chains.
The evolving regulatory landscape and increasing healthcare cost containment pressures from governments and private organizations, potentially affecting product pricing and market access.
Ongoing innovation and intense competition within the medical device and diagnostics sector, requiring continuous R&D investment and product differentiation for market share.
Abbott Laboratories is a global healthcare company with headquarters in Abbott Park, Illinois, known for its innovative solutions in diagnostics, medical devices, nutrition, and pharmaceuticals, operating in over 160 countries.
QUANT SCORE
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.
